Castellaro et al. have demonstrated that by activating the NF-κB/STAT3/ERK cascade, an association between breast cancer cells and macrophages stimulates tamoxifen and ICI 182,780 resistance [71]. This evidence concerns the gene NFKB1 and breast cancer.